Amanote Research
Register
Sign In
An Antiidiotypic Antibody That Recognizes the Beta-Adrenergic Receptor.
Journal of Clinical Investigation
- United States
doi 10.1172/jci110550
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
May 1, 1982
Authors
C J Homcy
S G Rockson
E Haber
Publisher
American Society for Clinical Investigation
Related search
Efficacy of Beta 1-Adrenergic Receptors Is Lower Than That of Beta 2-Adrenergic Receptors.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Reduced Beta-Adrenergic Receptor Activation Decreases G-Protein Expression and Beta-Adrenergic Receptor Kinase Activity in Porcine Heart.
Journal of Clinical Investigation
Medicine
The Role of Beta−Adrenergic Receptor Blockers in Autism
American Journal of Psychiatry and Neuroscience
Beta-Adrenergic Agonist Activity of a Monoclonal Anti-Idiotypic Antibody.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Monoclonal Antibody SZ-117 That Recognizes Filamin a Derived From Tumor Cells
Hybridoma
Alpha- And Beta-Adrenergic Receptor Blockade in the Treatment of Hypertension.
Heart
Cardiovascular Medicine
Cardiology
Analysis of Receptor for Vibrio choleraeEl Tor Hemolysin With a Monoclonal Antibody That Recognizes Glycophorin B of Human Erythrocyte Membrane
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Responsiveness to Beta-Adrenergic Receptor Stimulation: The Effects of Age Are Cardioselective.
British Journal of Clinical Pharmacology
Pharmacology
Beta-Adrenergic Blockers
Circulation
Cardiovascular Medicine
Physiology
Cardiology